menu
    • menu

    Company profile for Ami Lifesciences Private Limited

    AMI-Lifesciences-PSE
    News
    Ami Have Received Cep Approval For Rivaroxaban,Used An Anti-Coagulating Agent

    08 Apr 2024

    // PRESS RELEASE

    Ami received CEP approval Gliclazide. With this approval, we're one step closer

    01 Mar 2024

    // PRESS RELEASE

    Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate

    23 Jan 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    AMI Lifesciences

    Contact Supplier

    Website

    CPhI India 2024

    Exhibiting

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Related CompaniesRelated Companies

    About

    Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory therapeutic areas, Ami offers a wide range of APIs, intermediates, key starting materials, as well as contract bulk manufacturing services. Ami's manufacturing units in Gujarat and Karnataka feature dedicated clean rooms for APIs and adhere to international standards like EU-GMP, WHO-GMP, PMDA, and COFEPRIS. Ami serves as a reliable partner for contract development and manufacturing, offering generic APIs to global pharma companies across more than 60 countries.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ami Lifesciences Private Limitedindia-flag Flag
    Country
    Country
    India
    Address
    Address
    701 to 710, 7th Floor, 1038 Lilleria, Gotri-Sevasi Road, New Alkapuri, Vadodar...
    Telephone
    Telephone
    +91 2652323046
    Client Email
    Email
    info@amilifesciences.com
    Client Website
    Website
    http://amilifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/amilifesciences/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-india-2024-91846.png

    CPhI India 2024

    Exhibiting

    envelop Contact Supplier

    CPhI India 2024

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/ami-lifesciences-private-limited-party-content-21814.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/ami-lifesciences-private-limited-party-content-98165.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2019

    read-more

      https://www.pharmacompass.com/pdf/party/content/ami-lifesciences-private-limited-party-content-9928.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Ami Have Received Cep Approval For Rivaroxaban,Used An Anti-Coagulating Agent
    Ami Have Received Cep Approval For Rivaroxaban,Used An Anti-Coagulating Agent

    08 Apr 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    08 Apr 2024
    Share Share
    Ami received CEP approval Gliclazide. With this approval, we're one step closer
    Ami received CEP approval Gliclazide. With this approval, we're one step closer

    01 Mar 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    01 Mar 2024
    Share Share
    Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate
    Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate

    23 Jan 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    23 Jan 2024
    Share Share
    Ami Lifesciences the USDMF submission of Mirogablin Besylate to the US FDA
    Ami Lifesciences the USDMF submission of Mirogablin Besylate to the US FDA

    01 Jan 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    01 Jan 2024
    Share Share
    USDMF for Finerenone API has been submitted to the USFDA
    USDMF for Finerenone API has been submitted to the USFDA

    29 Sep 2023

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    29 Sep 2023
    Share Share
    Ami for being shortlisted as a finalist for the Reg.Achievement of theYear award
    Ami for being shortlisted as a finalist for the Reg.Achievement of theYear award

    28 Sep 2023

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    28 Sep 2023
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Ambroxol Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2023-168 - Rev 00

    Issue Date : 2023-08-23

    Type : Chemical

    Substance Number : 1489

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10118

    Registrant's Address : 2nd Floor, Prestige Plaza-40, Urmi Society, Near Urmi Cross Road, BPC Road, Akota, Vadodara-390 020, Gujarat, India

    Initial Date of Registration : 2023-11-01

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-08-11

    Valid Till : 2025-06-26

    Written Confirmation Number : WC-0054

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Hanmi Pharmaceutical Co., Ltd.

    Registration Date : 2023-02-27

    Registration Number : 20221028-45-B-470-06(1)

    Manufacturer Name : Ami Lifesciences Private Limited

    Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Dist : Vadodara, Gujarat State India

     VMF CN, MX arrow-down
    ✖
    Available Reg. Filing : CN, MX
    AUDIT
    AMI Lifesciences

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Diacerein

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 38766

    Submission : 2023-09-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2015-173 - Rev 02

    Issue Date : 2022-04-04

    Type : Chemical

    Substance Number : 2409

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-08-11

    Valid Till : 2025-06-26

    Written Confirmation Number : WC-0054

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 59680-014

    Start Marketing Date : 2024-04-09

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Huseeed Co., Ltd.

    Registration Date : 2021-11-30

    Registration Number : 20180515-209-J-27(6)

    Manufacturer Name : Ami Lifesciences Pvt. Ltd.

    Manufacturer Address : Block No. 82/B, ECP Road, At & Post. Karakhadi-391 450, Taluka:Padra, Dist.Vadodara, Gujarat, India

     VMF Others AUDIT
    AMI Lifesciences

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Tadalafil

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37995

    Submission : 2023-02-10

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2014-339 - Rev 03

    Issue Date : 2024-02-14

    Type : Chemical

    Substance Number : 2606

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-08-11

    Valid Till : 2025-06-26

    Written Confirmation Number : WC-0054

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Gapi Bio Co., Ltd.

    Registration Date : 2019-10-14

    Registration Number : 20191014-203-I-583-16

    Manufacturer Name : Ami Lifesciences Private Limited

    Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Dist : Vadodara, Gujarat State India

     VMF MX, CN arrow-down
    ✖
    Available Reg. Filing : MX, CN
    AUDIT
    AMI Lifesciences

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Tranexamic Acid

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Exhibiting